Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

SPKM-001 neutralizes Delta and Delta Plus variants of SARS-CoV-2 in vivo

Sep. 8, 2021

IMM-BCP-01 neutralizes SARS-CoV-2 Lambda and Delta Plus variants in preclinical tests

Sep. 8, 2021

nCoVmab1 prevents SARS-CoV-2 infection and significantly inhibits viral replication in vivo

Sep. 8, 2021

In vitro lung models of COVID-19 developed using stem cell-derived human lung organoids

Sep. 7, 2021

Discovery of novel new anti-cryptosporidial lead, SLU-2633

Sep. 7, 2021

Discovery of novel potent pan-serotypic dengue antivirals

Sep. 6, 2021

Mycobacterium tuberculosis inhibits the NLRP3 inflammasome through PknF to escape host immunity

Sep. 6, 2021

Aryl guanidine derivatives for invasive fungal infections found thanks to new mechanism of action

Sep. 6, 2021

SBIR grant supports Felix Biotechnology's work on engineering bacteriophage

Sep. 3, 2021

New compounds reduce intracellular c-di-GMP content in Pseudomonas aeruginosa

Sep. 2, 2021

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...